Mind Medicine Australia (MMA) is delighted to bring leading psychedelic researchers Dr Ben Sessa (Bristol, UK) and Dr Lauren Macdonald (London, UK) to Australia this October and November to lead the residential training for MMA’s leading Certificate in Psychedelic-Assisted Therapies (CPAT) program.
Dr Sessa has been at the forefront of psychedelic and cannabis research and clinical medicine in the UK for over 15 years. He has taken part in research projects at Bristol University, Cardiff University and Imperial College London with LSD, psilocybin, DMT, ketamine and MDMA – receiving and/or administering all of these compounds in legal research settings. Dr Macdonald is a psychiatry doctor and therapy guide at the Centre for Psychedelic Research, Imperial College London. She has worked on trials studying psilocybin-assisted therapy for anorexia nervosa and fibromyalgia, and DMT for treatment-resistant depression. After completing the CPAT training, Dr Sessa will be delivering a series of Public Keynote presentations and Workshops for Clinicians, Professionals and Leaders on Psychedelic-Assisted Therapies in Melbourne (Mon Nov 13, Tues Nov 14), Canberra (Weds Nov 15, Thurs Nov 16) and Sydney (Thurs Nov 16, Fri Nov 17). These events will provide an opportunity for clinicians and interested members of the public to learn more about these novel therapies. A limited number of Medical and Allied Health Students may also register for these very special workshops. His lecture, entitled Psychedelic-Assisted Therapies: The New Frontier in Treatments for Mental Illness, will explain:- What psychedelic drugs are
- Safety of psychedelic drugs in the treatment of depression, trauma, eating disorders, addictions and other conditions
- Psychedelics and Neuroplasticity
- How psychedelic-assisted therapies work clinically?
- Protocols for delivering psychedelic-assisted therapy safely and effectively
- And lots more…
- Neuropharmacology of MDMA and psilocybin and dosing protocols
- Preparing the therapist + facility/clinic
- What to expect / how to be ready
- Key features of the “set and setting”
- The “patient journey”
- Patient selection (inclusion and exclusion criteria, when to know that PAT might be the most appropriate next option)
- Obtaining consent (key concepts / risks to explain)
- Supportive care during drug tapering
- Preparation sessions
- Treatment sessions
- Appropriate behaviours
- Managing edge cases
- Key differences to standard therapy approaches
- Managing integration
No comments:
Post a Comment